Database and Biobank of Patients With Hypersensitivity Pneumonitis (PFBIO-HP)

Nils Hoyer

Status: Enrolling

Conditions: Hypersensitivity Pneumonitis

Study type: Observational

Funder types: Other

Identifiers

NCT05549635

PFBIO-HP

Details and patient eligibility

About

Sub-study of the main Pulmonary Fibrosis Biomarker (PFBIO) cohort (NCT02755441), recruiting patients with an MDT-diagnosis of hypersensitivity pneumonitis (HP). Patients are included for the collection of blood samples and regular clinical data.

The database and biobank will be available for studies of HP, and can be directly compared to the main PFBIO cohort, which has recruited patients with Idiopathic pulmonary Fibrosis (IPF) since 2016.

Biomarkers will be assessed as diagnostic and prognostic. Further subtyping of HP, based on blood markers (including precipitins) will also be possible with the PFBIO-HP project.

Enrollment: 50 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of HP at an MDT conference according to the current international guidelines
• Age of 18 years or older
• The patients must be capable of giving informed consent

Exclusion criteria

• Unable to sign informed consent

Trial design

50 participants in 1 patient group

Patients with an MDT-diagnosis of hypersensitivity pneumonitis (HP)

Description:

The overall inclusion criteria of patients in the HP cohort are: * Diagnosis of HP at an MDT conference according to the current international guidelines * Age of 18 years or older * The patients must be capable of giving informed consent